Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glauber, H. S.
Right arrow Articles by Brown, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glauber, H. S.
Right arrow Articles by Brown, J. B.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 15, Issue 7 870-876, Copyright © 1992 by American Diabetes Association

ARTICLES

Use of health maintenance organization data bases to study pharmacy resource usage in diabetes mellitus

HS Glauber and JB Brown
Center for Health Research, Kaiser Permanente Northwest Region, Portland, Oregon.

OBJECTIVE--To evaluate use of medications by patients with diabetes. RESEARCH DESIGN AND METHODS--We analyzed the computerized pharmacy data base of a large health maintenance organization to evaluate cost impact and patterns of usage for all pharmacy products by a defined population of diabetic patients. RESULTS--Diabetic patients received 31.2 dispenses/yr compared with 11.5 for control patients. Total pharmacy costs were threefold higher for diabetic patients ($621 vs. 207/yr) and accounted for approximately 17% of their total health-care costs. Products specifically for the care of diabetes averaged $175/yr or approximately 4.5% of their total health-care costs: 57% received an oral hypoglycemic agent, 34% received insulin, and 6% received both. Cardiovascular drugs accounted for 29% of total costs. There was increased use of most classes of medication by patients with diabetes. CONCLUSIONS--Health maintenance organization management data bases, particularly those storing pharmacy dispensing data, provide useful information on the impact of chronic disease. People with diabetes receive a greater number of most types of medication with a greater overall cost than do nondiabetic people. Previous studies have underestimated the contribution of pharmacy purchases to the costs of caring for a diabetic population.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Clin PharmacolHome page
Y.-L. He, R. Sabo, G. Sunkara, M.-N. Bizot, G.-J. Riviere, S. Leon, M. Ligueros-Saylan, W. P. Dole, and D. Howard
Evaluation of Pharmacokinetic Interactions Between Vildagliptin and Digoxin in Healthy Volunteers
J. Clin. Pharmacol., August 1, 2007; 47(8): 998 - 1004.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. A. Erkens, O. H. Klungel, R. P. Stolk, J. A. Spoelstra, D. E. Grobbee, and H. G.M. Leufkens
Cardiovascular Drug Use and Hospitalizations Attributable to Type 2 Diabetes
Diabetes Care, August 1, 2001; 24(8): 1428 - 1432.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
J. B. Brown, K. L. Pedula, and A. W. Bakst
The Progressive Cost of Complications in Type 2 Diabetes Mellitus
Arch Intern Med, September 13, 1999; 159(16): 1873 - 1880.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1992 by the American Diabetes Association.